GlassScriptPhysician profile
Shobha Gupta
NPI 1306883038
$3,991.09
in general payments reported to CMS, 2019-2025
16 companies · $380 in 2025
The $380 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $797 · 2020: $111 · 2021: $162 · 2022: $937 · 2023: $1,223 · 2024: $381 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,984.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,984.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,037.86 | 2019-2025 | Invega Sustenna, Spravato, Invega |
| Otsuka America Pharmaceutical, INC. | $677.21 | 2019-2024 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Teva Pharmaceuticals USA, INC. | $465.51 | 2019-2023 | Austedo Xr, Uzedy |
| Glaxosmithkline, LLC. | $456.51 | 2019-2024 | Arexvy |
| Amgen INC. | $249.98 | 2023-2024 | Repatha, Otezla |
| Genzyme Corporation | $223.33 | 2025 | |
| Galderma Laboratories, L.P. | $125.00 | 2025 | Nemluvio |
| Lilly USA, LLC | $124.99 | 2023 | Mounjaro |
| Alkermes, INC. | $110.16 | 2022-2025 | Aristada, Aristada Initio |
| Sunovion Pharmaceuticals INC. | $109.92 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $107.51 | 2022 | |
| Csl Behring | $101.75 | 2024 | Hizentra |
| Mylan Specialty L.P. | $91.59 | 2020 | |
| Abbvie INC. | $69.74 | 2021-2023 | |
| Avanir Pharmaceuticals, INC. | $20.39 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $19.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shobha Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.